Navigation Links
New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections
Date:10/8/2007

RARITAN, N.J., Oct. 8 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. today announced results from a Phase III trial that showed that investigational antibiotic ceftobiprole was found to clinically cure 86% of patients with diabetic foot infections -- including some infections that were caused by methicillin-resistant Staphylococcus aureus (MRSA).

These data were presented at the 45th annual meeting of the Infectious Disease Society of America (IDSA) in San Diego, California. Ceftobiprole is licensed from, and is being co-developed with, Basilea Pharmaceutica Ltd.

Staphylococcus aureus is the predominant Gram-positive+ bacteria associated with many infections, including complicated skin and skin structure infections (cSSSI) and is carried by approximately 25-30% of the U.S. population. During the last 30 years, MRSA has become more prevalent as a cause of complicated skin and skin structure infections, including diabetic foot infections, which are particularly challenging to treat. In 1974, MRSA accounted for 2% of all Staphylococcus infections in the U.S. In 2004, this figure had risen to 63%.

According to the American Diabetes Association (ADA), nearly 21 million Americans suffer from diabetes. Diabetic foot infections can develop in the skin, muscle, or bones of the foot as a result of nerve damage and poor circulation associated with diabetes. A recent ADA study approximates that as many as 9% of Americans with diabetes will develop a diabetic foot infection, and that those who do develop such an infection are 55.7 times more likely to require hospitalization and 154.5 times more at risk of amputation.

Ceftobiprole belongs to a class of antibacterial agents known as cephalosporins, which are used to treat serious infections caused by Gram- negative++ and Gram-positive+ bacteria. In clinically evaluable patients, 500mg of ceftobiprole administered intravenously every eight hours (500mg IV q8h) demonst
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development,L.L.C.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
2. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
3. Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis
4. Gabapentin Shown Effective for Fibromyalgia Pain
5. ApoCells Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
6. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
7. XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine or Vinorelbine in Treating Non-Small Cell Lung Cancer
8. Soliris Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
9. Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and Effective in Colorectal Cancer with Liver Metastases
10. Biotheras Imprime PGG Enhanced Effectiveness of Avastin in Cancer Study
11. Targanta Study Shows Oritavancin Treatment Effective in a Mouse Model of Anthrax

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009).... 20 Smith & Nephew ...o announce the signing of a technology development...ense that may lead to the creation of a fracture f...ment of the limbs of soldiers who sustain battlefi...d Research Projects Agency (DARPA), the central re...
(Date:11/19/2009).... 19 Warner Chilcott plc (Nasdaq: ...sly announced secondary offering of 20,000,000 of ...2.25 per share. The selling shareholders include ...erchant Banking, J.P. Morgan Partners (advised by ...rtain other institutional investors and members of...
(Date:11/19/2009)...9 In response to an ever-increasin...al medicines, Operation Pangea II, involving 24 co... Health Organization,s International Medical Produ...light the dangers of buying medicines online. ,...ries of arrests and the seizure of thousands of po...
Breaking Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Human Genome Sciences Announces Closing of Public Offering 13334 1Human Genome Sciences Announces Closing of Public Offering 13334 2Human Genome Sciences Announces Closing of Public Offering 13334 3New Analysis 3A Women of Low Socio Economic Status Face Unique Challenges Related to Smoking Smoking Ban Policies 53498 1New Analysis 3A Women of Low Socio Economic Status Face Unique Challenges Related to Smoking Smoking Ban Policies 53498 2New Analysis 3A Women of Low Socio Economic Status Face Unique Challenges Related to Smoking Smoking Ban Policies 53498 3New Analysis 3A Women of Low Socio Economic Status Face Unique Challenges Related to Smoking Smoking Ban Policies 53498 4New Analysis 3A Women of Low Socio Economic Status Face Unique Challenges Related to Smoking Smoking Ban Policies 53498 5National Institutes of Health Chooses Web of Science 28R 29 to Power electronic Scientific Portfolio Assistant 28eSPA 29 13333 1National Institutes of Health Chooses Web of Science 28R 29 to Power electronic Scientific Portfolio Assistant 28eSPA 29 13333 2
(Date:11/20/2009)... PRINCETON, NJ, Nov. 20 /PRNewswire-FirstCall/ - N...a Special Meeting of Shareholders will be held on ...ing is to consider approval of two special resolut...nd authorize the sale of all or substantially all ...ms provided for in the asset purchase agreement da...
(Date:11/20/2009)..., MADISON, N.J., Nov. 20 /PRNewswire-FirstCall/ -...rus may have peaked in late October, but the pande...f illness in all age groups, including the elderly...ncorporated (NYSE: DGX ), the world,s leading pr...ices. ,, In its most recent Quest Diagnostics ...
(Date:11/20/2009)...AS VEGAS, Nov. 20 The f...e Director of the Nevada Health Care Association: ...ommends and thanks Senate Majority Leader Harry Re...closer toward our goal of protecting every Nevada ...re, and preserving the strength and viability of o...
(Date:11/20/2009)... Washington) November 20, 2009Emergency medical se...an estimated 350,000 cardiac arrests each year. O...iac arrest survive. Better quality cardiopulmonar...providers may be associated with better patient ou...) is the largest clinical research network to stud...
(Date:11/20/2009)...tivity remains high and is expected to continue, C... News) -- Some areas of the United States are seei...health official said Friday, and while the disease... the 46 states reported last week. , "We are be... around the country, but there is still a lot of i...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Swine Flu Declining in Some Parts of U.S. 2Health News:Swine Flu Declining in Some Parts of U.S. 3
... H.B. 5285 Enables BCBSM to expand ...Mich., April 16 The Blue Cross and Accident,Fund ...nfair advantage into,a monopoly rather than benefi...ased, tax-paying insurance companies that,employ m...
...d Workers at Stockton Retirement,Home, STOCKTON, ...rd has recommended a new election be held at the,O...inding management,violated federal law by threaten...egivers,first voted to become members of SEIU Unit...
...008) A new discovery by University of Minnesota r...ow the spinal cord controls how people walk. Thes...al nervous system maladies such as Parkinson,s dis...scovered its possible that the human nervous syste...
... U.S. Pharmacopeial (USP) Convention today announc.... USP is the official standards-setting body for p...the United States. It also sets standards that are... graduate students to spend twelve weeks at USP wo...
...rated,(NYSE: AFL ) announced today that it will r...arket closes on April 23, 2008., (Logo: http://w...), In conjunction with the earnings release, Afla...and CEO Dan Amos,will discuss first quarter result...
...ed 13.4% lower chance of recovery, study finds , ...our chances for surviving a cardiac arrest are 13....l on the weekend versus a weekday, according to ne...rvival rate remains the same. , "A higher death ra...
Other Medicine News:Health News:Coalition For A Fair & Competitive Insurance Market Says Senate Should Reject the Blues Attempt to Expand Their Unfair Advantage 2Health News:Coalition For A Fair & Competitive Insurance Market Says Senate Should Reject the Blues Attempt to Expand Their Unfair Advantage 3Health News:Coalition For A Fair & Competitive Insurance Market Says Senate Should Reject the Blues Attempt to Expand Their Unfair Advantage 4Health News:NLRB Orders New Union Election at O'Connor Woods 2Health News:U of M researchers identify process that may help treat Parkinson's, spinal cord injuries 2Health News:USP announces 2008 summer internship program participants 2Health News:Aflac Incorporated To Release First Quarter Results on April 23, 2008 2
...th the OLA2500 High Speed Sorter (HSS) system, ded...ements. As a front-end sample-processor, the OLA25...ample tubes to their destination racks quickly to...rrors. Post-analytical archiving to any archive ra...
COCOON Disposable Paediatric - Neonatal / Child
Bair Hugger® Model 536 - Pediatric Blanket Short
CareQuilt® Pediatric Warming Blanket
Medicine Products: